Shenzhen YHLO Biotech Co., Ltd.

¥11.08As of Sun 8 Nov 2026, 12:00 UTC
SSE:688575Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (22.29%)
Div yield 0.19%
ROE 5.83%
Medical Devices
Beta (5Y) 0.26
PE TTM 62.67
TSR TTM (26.12%)
Mkt cap ¥6.331B
ROIC 6.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
14.79%
(60.29%)
Hold 10|11|4|7|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.14
0.15
0.16
9.64%
6.58%
11.85%
11.97%
Revenue¥M
307.6
306.3
311.0
322.4
2.10%
(2.39%)
(0.26%)
2.13%
Peers (US$949.0M)
Cap (US$)
PE
959.0M
247.4x
944.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.797
0.048
0.046
EBIT/Intx
2.909
1.100
1.092
Own earn%
(32.63)
(30.03)
(49.68)
Sh yield%
28.36
34.38
27.78
Owners
Insiders/Inst%
4.25
69.16
Short interest%
4.17
SBC / revenue%
4.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
16–22
$1 testx
—
Incr. ROIC%
7